ExonHit Therapeutics S.A. has announced the availability of its new SpliceArray™ for use in studying mouse models of human disease. These SpliceArrayTM products help our clients accelerate their therapeutic target discovery and validation efforts. Using our high resolution expression profiling analysis, we identify novel transcripts coding for new protein variants that may be involved in various genetic disorders such as oncology, central nervous system, or immune system disorders. This mouse SpliceArrayTM products represent the achievement of more two years of work by our R&D team after the launch of the Human genome SpliceArrayTM and the rat genome SpliceArrayTM.